Neeru Bose
Medical Oncology · Crown Point, INNPI 1962668038
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for medical oncology clinicians in IN, where the typical reported total is $2,472.
Across 159 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$314
- Merck$245
- Genentech USA, Inc.$207
- AstraZeneca$205
- Novartis$193
- E.r. Squibb & Sons, L.L.C.$193
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,54998%
- Education$392%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 20 | $314 |
| Merck | 17 | $245 |
| Genentech USA, Inc. | 13 | $207 |
| AstraZeneca(2 entities) | 13 | $205 |
| Novartis | 12 | $193 |
| E.r. Squibb & Sons, L.L.C. | 12 | $193 |
| Pharmacyclics LLC, An Abbvie Company | 7 | $131 |
| Pfizer | 12 | $126 |
| Amgen | 8 | $119 |
| Exelixis Inc. | 6 | $115 |
| Tesaro, Inc. | 2 | $82 |
| Lilly USA, LLC | 4 | $68 |
| Bristol Myers Squibb | 3 | $64 |
| Astellas Pharma US Inc | 4 | $60 |
| Incyte Corporation | 4 | $57 |
| Bayer | 3 | $57 |
| Medtronic | 1 | $33 |
| EMD Serono, Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Eisai Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $23 |
| Dendreon Pharmaceuticals LLC | 1 | $22 |
| Sanofi | 1 | $22 |
| Seagen Inc. | 1 | $20 |
| Aurobindo Pharma USA, Inc. | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $14 |
| Dova Pharmaceuticals | 1 | $14 |
| Sandoz | 1 | $14 |
| Array Biopharma Inc | 1 | $13 |
| Gilead | 1 | $12 |
How this compares
$2,589 in reported general payments places this provider in the 50th percentile of 67 medical oncology providers in Indiana.
Other medical oncology in Crown Point
- Arshad HusainCrown Point$6K
- Mohamed FarhatCrown Point$1K
- Costantine AlbanyLafayette$212K
- Sunil BabuFort Wayne$166K
- Natraj AmmakkanavarIndianapolis$129K
- Rafat AnsariMishawaka$90K
- Bert OneilIndianapolis$89K
- Pablo BedanoIndianapolis$52K
- Gregory SmithIndianapolis$46K
- Ashwin VasudevamurthyIndianapolis$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.